Morgan Stanley’s Celularity CELU Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $196 | Buy |
100
+50
| +100% | +$98 | ﹤0.01% | 7572 |
|
2025
Q1 | $87 | Hold |
50
| – | – | ﹤0.01% | 7597 |
|
2024
Q4 | $104 | Hold |
50
| – | – | ﹤0.01% | 7461 |
|
2024
Q3 | $149 | Sell |
50
-300
| -86% | -$894 | ﹤0.01% | 7403 |
|
2024
Q2 | $1.1K | Sell |
350
-8,500
| -96% | -$26.6K | ﹤0.01% | 7142 |
|
2024
Q1 | $46.3K | Sell |
8,850
-1,411
| -14% | -$7.38K | ﹤0.01% | 6242 |
|
2023
Q4 | $25.4K | Buy |
10,261
+2,244
| +28% | +$5.55K | ﹤0.01% | 6577 |
|
2023
Q3 | $17.8K | Sell |
8,017
-2,432
| -23% | -$5.4K | ﹤0.01% | 6522 |
|
2023
Q2 | $55.7K | Buy |
10,449
+4,738
| +83% | +$25.2K | ﹤0.01% | 6170 |
|
2023
Q1 | $35.4K | Sell |
5,711
-1,392
| -20% | -$8.63K | ﹤0.01% | 6407 |
|
2022
Q4 | $91.6K | Sell |
7,103
-2,891
| -29% | -$37.3K | ﹤0.01% | 6013 |
|
2022
Q3 | $230K | Buy |
9,994
+2,327
| +30% | +$53.6K | ﹤0.01% | 5665 |
|
2022
Q2 | $260K | Buy |
7,667
+2,679
| +54% | +$90.8K | ﹤0.01% | 5764 |
|
2022
Q1 | $435K | Sell |
4,988
-15
| -0.3% | -$1.31K | ﹤0.01% | 5495 |
|
2021
Q4 | $256K | Sell |
5,003
-97
| -2% | -$4.96K | ﹤0.01% | 5931 |
|
2021
Q3 | $361K | Buy |
5,100
+3,960
| +347% | +$280K | ﹤0.01% | 5686 |
|
2021
Q2 | $116K | Sell |
1,140
-912
| -44% | -$92.8K | ﹤0.01% | 6289 |
|
2021
Q1 | $207K | Buy |
2,052
+386
| +23% | +$38.9K | ﹤0.01% | 5642 |
|
2020
Q4 | $184K | Buy |
+1,666
| New | +$184K | ﹤0.01% | 5635 |
|
2020
Q2 | – | Sell |
-35
| Closed | -$3K | – | 6608 |
|
2020
Q1 | $3K | Sell |
35
-83
| -70% | -$7.11K | ﹤0.01% | 6318 |
|
2019
Q4 | $12K | Buy |
+118
| New | +$12K | ﹤0.01% | 6216 |
|